EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mutation Analysis of TMB ‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications

Yuko Chikaishi, Hiroshi Matsuoka, Eiji Sugihara, Mayu Takeda, Makoto Sumitomo, Seiji Yamada, Gaku Inaguma, Yusuke Omura, Yeongcheol Cheong, Yosuke Kobayashi, Masaya Nakauchi, Junichiro Hiro und 6 weitere

Cancer Science · 2025

DOI: 10.1111/cas.16455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Yuko Chikaishi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Fujita Health University, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is well characterized in terms of genetic mutations and the mechanisms by which they contribute to carcinogenesis. Mutations in APC , TP53 , and KRAS are common in CRC, indicating key roles for these genes in tumor development and progression. However, for certain tumors with low frequencies of these mutations that are defined by tumor location and molecular phenotypes, a carcinogenic mechanism dependent on BRAF mutations has been proposed. We here analyzed targeted sequence data linked to clinical information for CRC, focusing on tumors with a high tumor mutation burden (TMB) in order to identify the characteristics of associated mutations, their relations to clinical features, and the mechanisms of carcinogenesis in tumors lacking the major driver oncogenes. Analysis of overall mutation frequencies confirmed that APC , TP53 , and KRAS mutations were the most prevalent in our cohort. Compared with other tumors, TMB‐high tumors were more frequent on the right side of the colon, had lower KRAS and higher BRAF mutation frequencies as well as a higher microsatellite instability (MSI) score, and showed a greater contribution of a mutational signature associated with MSI. Ranking of variant allele frequencies to identify genes that play a role early in carcinogenesis suggested that mutations in genes related to the DNA damage response (such as ATM and POLE ) and to MSI (such as MSH2 and MSH6 ) may precede BRAF mutations associated with activation of the serrated pathway in TMB‐high tumors. Our results thus indicate that TMB‐high tumors suggest that mutations of genes related to mismatch repair and the DNA damage response may contribute to activation of the serrated pathway in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMutationHumansMicrosatellite InstabilityProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)FemaleMaleDNA Mutational AnalysisTumor Suppressor Protein p53Middle AgedAgedBiomarkers, TumorAdenomatous Polyposis Coli ProteinGene Frequency

Stichwörter der Autor:innen

CpG island methylator phenotype (CIMP)colorectal cancermolecular phenotypeprecision medicinetumor mutation burden (TMB)

Substanzen

Proto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)BRAF protein, humanKRAS protein, humanTumor Suppressor Protein p53TP53 protein, humanBiomarkers, TumorAdenomatous Polyposis Coli Protein

Autor:innen und Institutionen

  • Department of Surgery, Fujita Health University, Toyoake, Aichi, Japan.
  • Research Promotion Headquarters, Open Facility Center, Fujita Health University, Toyoake, Japan.
  • Oncology Innovation Center, Fujita Health University, Toyoake, Aichi, Japan.
  • Faculty of Health and Medical Sciences, Aichi Syukutoku University, Nagakute, Aichi, Japan.
  • Department of Advanced Robotic and Endoscopic Surgery, Fujita Health University, Toyoake, Aichi, Japan.
  • Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan.

ORCID-Profile: Hiroshi Nishihara, Tetsuya Takimoto

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Chikaishi, Y., Matsuoka, H., Sugihara, E., Takeda, M., Sumitomo, M., Yamada, S., Inaguma, G., Omura, Y., Cheong, Y., Kobayashi, Y., Nakauchi, M., Hiro, J., Masumori, K., Otsuka, K., Nishihara, H., Suda, K., Saya, H., & Takimoto, T. (2025). Mutation Analysis of TMB ‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications. Cancer Science. https://doi.org/10.1111/cas.16455

Vancouver

Chikaishi Y, Matsuoka H, Sugihara E, Takeda M, Sumitomo M, Yamada S, et al. Mutation Analysis of TMB ‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications. Cancer Science. 2025. doi:10.1111/cas.16455

BibTeX
@article{Chikaishi2025,
  author = {Chikaishi, Yuko and Matsuoka, Hiroshi and Sugihara, Eiji and Takeda, Mayu and Sumitomo, Makoto and Yamada, Seiji and Inaguma, Gaku and Omura, Yusuke and Cheong, Yeongcheol and Kobayashi, Yosuke and Nakauchi, Masaya and Hiro, Junichiro and Masumori, Koji and Otsuka, Koki and Nishihara, Hiroshi and Suda, Koichi and Saya, Hideyuki and Takimoto, Tetsuya},
  title = {Mutation Analysis of TMB ‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.16455}
}
Kostenlos starten →